Smart Pills Market Outlook
Smart pills refer to the ingestible medical devices that comprise of sensors, cameras, trackers, patches, etc. They are utilized to record various physiological metrics and processes in the body. Smart pills aid in providing improved and accurate therapy, diagnostics, monitoring, etc., while eliminating the need for invasive procedures.
The global smart pills market reached a value of US$ 3.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2027, exhibiting at a CAGR of 7.8% during 2022-2027.
At present, several manufacturers are introducing innovative product variants with advanced batteries and onboard memory. Smart pills also assist in remote patient monitoring and telemedicine. Additionally, they offer wireless transmission of information in real-time and precise measurement of the effects of the medication.
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Smart Pills Market Trends:
The escalating prevalence of cancer and malignant gastrointestinal (GI) disorders is shifting the consumer preferences from conventional diagnostic techniques, such as endoscopy, which is primarily driving the smart pills market. In line with this, the increasing adoption of smart pills for providing multidimensional pictures of the body’s internal parts non-invasively, over endoscopy devices which come with high risks of infection transmission and esophageal tearing, is further catalyzing the market growth.
Moreover, the expanding pediatric population, who are relatively more vulnerable to targeted diseases, is acting as another significant growth-inducing factor. Besides this, the rising demand for minimally invasive surgeries (MIS) to diagnose and treat chronic diseases is also augmenting the global market. Furthermore, the elevating utilization of smart pills in the defense sector to monitor the core body temperatures of soldiers in real-time is positively influencing the product demand. This, in turn, is anticipated to fuel the smart pills market over the forecasted period.
Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.
Competitive Landscape with Key Players:
- CapsoVision Inc.
- Check-Cap Ltd.
- General Electric Company
- IntroMedic Co. Ltd.
- Jinshan Science & Technology (Group) Co. Ltd.
- Koninklijke Philips N.V.
- Medtronic plc
- Olympus Corporation
- PENTAX Medical (Hoya Corporation).
Key Market Segmentation:
The report has categorized the market based on target area, disease indication, application, and end user.
Breakup by Target Area:
- Small Intestine
- Large Intestine
Based On Disease Indication:
- Esophageal Diseases
- Small Bowel Diseases
- Colon Diseases
Breakup by Application:
- Capsule Endoscopy
- Drug Delivery
- Patient Monitoring
- Diagnostic Centers
- Research Institutes
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800